Search research articles
Contact Us
Filters
Showing results (31-40 of 137) with videos related to
Page
of 14
Sort By:
Scandinavian Journal of Immunology
|
June 28, 2003
Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis
A R Glabinski, B Bielecki, R M Ransohoff
Lancet (London, England)
|
May 26, 1990
Vitamin B12 deficiency and multiple sclerosis
R M Ransohoff, D W Jacobsen, R Green
Journal of Neuroscience Research
|
September 15, 1996
Transcriptional regulation of chemokine gene expression in astrocytes
S Majumder, L Z Zhou, R M Ransohoff
Journal of Immunology (Baltimore, Md. : 1950)
|
July 22, 1999
TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA
Y Han, Z H Zhou, R M Ransohoff
Journal of Computer Assisted Tomography
|
July 1, 1995
Unusual long-standing Gd-DTPA enhancement in a chronic progressive myelopathy
B Weinstock-Guttman, J S Ross, R M Ransohoff
Neurology
|
April 1, 1990
Noncommunicating syringomyelia in multiple sclerosis: detection by magnetic resonance imaging
R M Ransohoff, G J Whitman, M A Weinstein
Cleveland Clinic Journal of Medicine
|
January 1, 1992
Experimental therapies for multiple sclerosis: current status
D E Goodkin, R M Ransohoff, R A Rudick
Cleveland Clinic Journal of Medicine
|
May 1, 1992
Pharmacotherapy of multiple sclerosis: current status
R A Rudick, D E Goodkin, R M Ransohoff
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 1, 1997
Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma
R P Kinkel, R A Rudick, R M Ransohoff
Der Nervenarzt
|
October 11, 2003
[Chemokine--possible new options for the treatment of multiple sclerosis]
C Trebst, R M Ransohoff, A Windhagen, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 137) with videos related to
Sort By:
Page
of 14
Scandinavian Journal of Immunology
|
June 28, 2003
Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis
A R Glabinski, B Bielecki, R M Ransohoff
Lancet (London, England)
|
May 26, 1990
Vitamin B12 deficiency and multiple sclerosis
R M Ransohoff, D W Jacobsen, R Green
Journal of Neuroscience Research
|
September 15, 1996
Transcriptional regulation of chemokine gene expression in astrocytes
S Majumder, L Z Zhou, R M Ransohoff
Journal of Immunology (Baltimore, Md. : 1950)
|
July 22, 1999
TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA
Y Han, Z H Zhou, R M Ransohoff
Journal of Computer Assisted Tomography
|
July 1, 1995
Unusual long-standing Gd-DTPA enhancement in a chronic progressive myelopathy
B Weinstock-Guttman, J S Ross, R M Ransohoff
Neurology
|
April 1, 1990
Noncommunicating syringomyelia in multiple sclerosis: detection by magnetic resonance imaging
R M Ransohoff, G J Whitman, M A Weinstein
Cleveland Clinic Journal of Medicine
|
January 1, 1992
Experimental therapies for multiple sclerosis: current status
D E Goodkin, R M Ransohoff, R A Rudick
Cleveland Clinic Journal of Medicine
|
May 1, 1992
Pharmacotherapy of multiple sclerosis: current status
R A Rudick, D E Goodkin, R M Ransohoff
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 1, 1997
Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma
R P Kinkel, R A Rudick, R M Ransohoff
Der Nervenarzt
|
October 11, 2003
[Chemokine--possible new options for the treatment of multiple sclerosis]
C Trebst, R M Ransohoff, A Windhagen, et al.
Page
of 14